Serotonin Anti-Aging Centers Expands Dallas Footprint with Five-Location Franchise Deal
Event summary
- Serotonin Anti-Aging Centers signed a five-location development agreement with AgeWell Longevity for Dallas and Collin County, Texas.
- The deal is led by physicians Dr. Mo Al-Obaidi and Dr. Shaam Mahasneh, marking the second franchise group in the Dallas–Fort Worth market.
- Serotonin already operates one location in Mansfield, Texas, and will now expand with five additional centers.
- Each new center will offer concierge-style services including longevity, hormone optimization, medical aesthetics, and preventative wellness.
The big picture
Serotonin’s deal underscores the accelerating demand for physician-guided longevity services, particularly in health-conscious regions like Texas. The franchise model allows rapid expansion while leveraging local medical expertise, a key differentiator in an increasingly crowded anti-aging market. This move follows broader industry trends where wellness brands are shifting toward evidence-based, concierge-style care to capture high-value patients.
What we're watching
- Market Penetration
- How Serotonin’s expansion in Dallas will impact its market share against competitors in the growing longevity sector.
- Physician-Led Growth
- Whether physician-led franchise models can sustain higher patient trust and retention compared to non-medical operators.
- Scalability Challenges
- The pace at which Serotonin can maintain clinical excellence while rapidly scaling across new locations.
Related topics